Intra-Cellular Ther (ITCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ITCI | JAZZ | EXEL | ||
| Company | Intra-Cellular Ther | Jazz Pharma Plc | Exelixis Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 131.90 | 240.70 | 50.55 | ||
| High | 131.98 | 242.00 | 50.71 | ||
| Low | 131.63 | 236.05 | 49.51 | ||
| Latest | 131.87 | 237.41 | 49.98 | ||
| Change | -0.05 | -2.42 | -0.17 | ||
| % Change | -0.04% | -1.01% | -0.34% | ||
| Volume | 16,062,900 | 660,100 | 2,104,200 | ||
| 20-Day Average Volume | 2,474,570 | 892,320 | 2,800,850 | ||
| Previous Close | 131.92 | 239.83 | 50.15 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 131.51 | 223.88 | 47.97 | ||
| 20-Day Raw Stochastic | 86.25% | 86.76% | 79.70% | ||
| 20-Day Relative Strength | 82.75 | 70.36 | 59.49 | ||
| Weighted Alpha | +83.21 | +118.55 | +24.01 | ||
| Today's Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Previous Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.13% since 03/25/25 | +3.42% since 05/18/26 | +0.28% since 05/18/26 | ||
| Low | 131.63 on 04/01/25 | 232.05 on 05/19/26 | 48.21 on 05/19/26 | ||
| High | 131.98 on 04/01/25 | 243.32 on 05/22/26 | 50.71 on 05/26/26 | ||
| 1-Month | |||||
| %Chg | +2.86% since 02/28/25 | +20.81% since 04/24/26 | +11.21% since 04/24/26 | ||
| Low | 131.18 on 03/05/25 | 198.16 on 04/27/26 | 43.50 on 05/04/26 | ||
| High | 131.98 on 04/01/25 | 243.32 on 05/22/26 | 51.63 on 05/14/26 | ||
| 3-Month | |||||
| %Chg | +57.89% since 12/31/24 | +25.63% since 02/26/26 | +12.87% since 02/26/26 | ||
| Low | 80.82 on 01/07/25 | 176.67 on 03/06/26 | 39.71 on 03/02/26 | ||
| High | 131.98 on 04/01/25 | 243.32 on 05/22/26 | 51.63 on 05/14/26 | ||
| 6-Month | |||||
| %Chg | +81.51% since 10/01/24 | +34.19% since 11/26/25 | +13.05% since 11/26/25 | ||
| Low | 70.90 on 10/07/24 | 156.95 on 01/08/26 | 39.71 on 03/02/26 | ||
| High | 131.98 on 04/01/25 | 243.32 on 05/22/26 | 51.63 on 05/14/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 14,047,056 | 14,895,816 | 12,562,722 | ||
| Shares Outstanding, K | 106,522 | 62,743 | 251,355 | ||
| Annual Sales | 680,850,000 | 4,267,590,000 | 2,320,130,000 | ||
| Annual Net Income | -74,680,000 | -356,150,000 | 782,570,000 | ||
| Last Quarter Sales | 199,220,000 | 1,068,900,000 | 610,810,000 | ||
| Last Quarter Net Income | -16,890,000 | 293,100,000 | 210,470,000 | ||
| 60-Month Beta | 0.46 | 0.27 | 0.38 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.16 on 02/21/25 | 6.34 on 05/05/26 | 0.87 on 05/05/26 | ||
| Earnings Date | 05/06/25 | 08/04/26 | 07/27/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 26.24 | 16.77 | ||